Serum and Semen Vitamin D Level With Semen Parameters

July 15, 2020 updated by: Mary Yonan, Assiut University

Correlation of Serum and Semen Vitamin D Level With Semen Parameters in Males

vitamin D may have multiple functions, one of them is modulating reproductive processes and the reproductive role of vitamin D is highlighted by expression of the vitamin D receptors in testis, male reproductive tract and sperms

Study Overview

Detailed Description

Semen analysis is the corner stone of infertility evaluation as it provides information on the functional status of the seminiferous tubules, epididymis and accessory sex glands. The methods on how the semen should be evaluated are provided by the World Health Organization Vitamin D is synthesized mainly in the skin, where ultraviolet ray B radiation converts 7-dehydrocholesterol to Vitamin D3. Then, Vitamin D3 undergoes two hydroxylation processes first in the liver and second in the kidney Serum 25(OH)D is the major circulating metabolite of vitamin D and reflects vitamin D inputs from cutaneous synthesis and dietary intake. The serum 25(OH)D level is the standard clinical measure of vitamin D status Vitamin D deficiency has been linked to various health disorders including boneheallth, cardiovascular, infectious, oncologic, musculoskeletal, neuropsychologic and reproductive disorders, as well as to overall mortality

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt, 71111
        • Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

The patients will be recruited from the out patient clinic of Andrology, Assuit university hospital.

One hundred and fifty individuals will be included divided into five groups according to semen parameters finding

Description

Inclusion Criteria

  • -males with different semen parameter finding
  • Age: 20-50 years

Exclusion Criteria:

  1. Varicocele.
  2. Genital tract infections.
  3. Primary and secondary hypogonadism
  4. Hormonal therapy.
  5. Calcium and vitamin D supplement.
  6. Hepatic or renal failure
  7. Diseases or drugs affecting vitamin D absorption -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
First group: semen parameter showing normospermic
  • group will include 30 male
  • Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
  • blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Other Names:
  • semen analysis
second group: semen parameter asthenozoospermic
  • group will include 30 male
  • Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
  • blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Other Names:
  • semen analysis
Third group: semen parameter oligozoospermic
  • group will include 30 male
  • Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
  • blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Other Names:
  • semen analysis
Forth groupsemen parameter: astheno-teratozoospermic,
  • group will include 30 male
  • Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
  • blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Other Names:
  • semen analysis
Fifth group semen parameter: oligo asthenoteratozoospermia
  • group will include 30 male
  • Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
  • blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Other Names:
  • semen analysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
correlation of serum and semen vitamin D level with semen parameters in males
Time Frame: A year
evaluation the level of vitamin D in serum and semen by using ELISA method and correlate it with semen parameters
A year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mary Younan, Resident, Assiut Univeristy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2018

Primary Completion (Actual)

July 13, 2020

Study Completion (Anticipated)

April 1, 2021

Study Registration Dates

First Submitted

March 20, 2018

First Submitted That Met QC Criteria

March 20, 2018

First Posted (Actual)

March 26, 2018

Study Record Updates

Last Update Posted (Actual)

July 16, 2020

Last Update Submitted That Met QC Criteria

July 15, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin D Deficiency

Clinical Trials on ELISA to evaluate serum and seminal vitamin D level

3
Subscribe